Skip to main content
    C

    CME Group Inc (CME)

    Official site

    FINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ

    $319.37
    +1.40 (+0.44%)

    Market Cap: $113.81B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    CME Group Inc (CME) Financials: Revenue, Profit and Cash Flow

    Updated Oct 21, 2026. Financial statements from company filings, amounts in US dollars.

    CME Group reported revenue of $6.52B for the fiscal year ended Dec 31, 2025, up 6.4% from the year before. That year, net income was $4.07B with a net margin of 62.5%, operating cash flow was $4.28B and free cash flow was $4.19B. The quarter ended Sep 30, 2026 had revenue of $1.74B and net income of $1.04B.

    Revenue and Margins

    The operating margin was 64.9% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $3.60B, a compound annual rate of 6.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$6.52B+6.4%86.1%64.9%62.5%
    Dec 2024$6.13B+9.9%86.1%64.1%57.5%
    Dec 2023$5.58B+11.1%85.1%61.6%57.8%
    Dec 2022$5.02B+7.0%85.0%60.1%53.6%
    Dec 2021$4.69B-4.0%82.2%56.4%56.2%
    Dec 2020$4.88B+0.3%82.5%54.0%43.1%
    Dec 2019$4.87B+13.0%81.5%53.2%86.9%
    Dec 2018$4.31B+18.2%81.7%60.5%45.5%
    Dec 2017$3.64B+1.4%84.5%63.4%111.5%
    Dec 2016$3.60BN/A84.9%61.2%42.7%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 15.3% from the year before. In the quarter ended Sep 2026, net income rose 14.5% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$6.52B$6.13B$5.58B$5.02B$4.69B$4.88B$4.87B$4.31B$3.64B$3.60B
    Cost of revenue$907.00M$850.30M$828.60M$753.10M$837.00M$856.50M$898.70M$789.40M$563.90M$543.20M
    Gross profit$5.61B$5.28B$4.75B$4.27B$3.85B$4.03B$3.97B$3.52B$3.08B$3.05B
    Operating income$4.23B$3.93B$3.44B$3.02B$2.65B$2.64B$2.59B$2.61B$2.31B$2.20B
    Net income$4.07B$3.53B$3.23B$2.69B$2.64B$2.11B$4.23B$1.96B$4.06B$1.53B
    EBITDAN/AN/AN/AN/A$3.37B$2.98BN/AN/AN/A$2.38B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$1.74B$1.71B$1.88B$1.65B$1.54B$1.69B$1.64B$1.53B$1.58B$1.53B$1.49B$1.44B
    Gross profit$1.50B$1.47B$1.66B$1.41B$1.30B$1.47B$1.44B$1.30B$1.37B$1.33B$1.28B$1.23B
    Operating income$1.14B$1.11B$1.31B$1.02B$972.60M$1.13B$1.11B$947.10M$1.02B$1.00B$959.60M$863.20M
    Net income$1.04B$1.04B$1.15B$1.18B$908.00M$1.03B$956.20M$874.60M$912.80M$883.20M$855.20M$814.60M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $3.48B by $938.80M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$198.42B$137.45B$129.71B$174.18B$196.78B$124.66B$75.22B$77.48B$75.79B$69.37B
    Current assets$165.36B$103.03B$94.89B$139.08B$161.76B$89.28B$39.57B$41.89B$46.91B$40.03B
    Cash and equivalents$4.42B$2.89B$2.91B$2.72B$2.83B$1.63B$1.55B$1.37B$1.90B$1.87B
    Total liabilities$169.70B$110.96B$102.97B$147.30B$169.38B$98.31B$49.06B$51.51B$53.38B$49.03B
    Short-term debt$55.80M$749.80M$0$16.00M$749.40M$0$49.70M$574.20M$0$37.54B
    Long-term debt$3.42B$2.68B$3.43B$3.42B$2.70B$3.44B$3.74B$3.83B$2.23B$2.23B
    Shareholder equity$28.73B$26.49B$26.74B$26.88B$27.40B$26.32B$26.13B$25.92B$22.41B$20.34B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$192.09B$194.68B$201.99B$198.55B$187.14B$179.91B$157.83B$137.45B$137.80B$123.38B$132.05B$129.71B
    Total liabilities$165.53B$168.16B$175.38B$169.82B$158.95B$152.17B$130.80B$110.96B$109.58B$95.74B$104.90B$102.97B
    Cash and equivalents$2.20B$2.14B$2.39B$4.42B$2.45B$1.98B$1.41B$2.89B$2.32B$1.79B$1.44B$2.91B
    Shareholder equity$26.56B$26.52B$26.62B$28.73B$28.19B$27.74B$27.03B$26.49B$28.22B$27.64B$27.15B$26.74B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 97.9% of operating cash flow. Dividends and share repurchases together came to 100.2% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$4.28B$3.69B$3.45B$3.06B$2.40B$2.72B$2.67B$2.44B-$1.75B$1.73B
    Capital expenditures$83.50M$94.00M$76.40M$89.70M$127.20M$197.50M$245.60M$116.70M$81.90M$91.80M
    Free cash flow$4.19B$3.60B$3.38B$2.97B$2.28B$2.52B$2.43B$2.32B-$1.83B$1.64B
    Dividends paid$3.93B$3.58B$3.24B$2.63B$2.19B$2.11B$1.70B$2.15B$1.99B$1.79B
    Share repurchases$266.10M$0$0N/AN/AN/AN/AN/AN/AN/A
    Investing cash flow$1.50B-$82.60M$20.90M-$489.80M$58.40M-$175.50M-$152.60M-$1.89B$179.90M$53.70M
    Financing cash flow$56.51B$5.08B-$48.34B-$25.38B$69.91B$47.25B-$4.72B-$1.08B-$1.99B-$1.62B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$1.09B$947.10M$1.26B$1.13B$968.10M$1.06B$1.12B$1.02B$1.00B$776.90M$892.70M$1.04B
    Capital expenditures$15.80M$23.60M$21.80M$32.50M$18.40M$18.40M$14.20M$26.20M$29.80M$18.20M$19.80M$20.80M
    Free cash flow$1.07B$923.50M$1.24B$1.10B$949.70M$1.04B$1.10B$991.70M$973.20M$758.70M$872.90M$1.02B
    Last 12 quarters

    Frequently Asked Questions About CME

    What is CME Group's annual revenue?

    CME Group reported revenue of $6.52B for the fiscal year ended Dec 31, 2025.

    How fast is CME Group's revenue growing?

    Revenue was up 6.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 9.1%.

    Is CME Group profitable?

    Yes. CME Group reported net income of $4.07B for the fiscal year ended Dec 31, 2025, with a net margin of 62.5%.

    How much free cash flow does CME generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $4.28B minus capital expenditures of $83.50M produced free cash flow of $4.19B.

    How much debt does CME Group have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $3.42B, short-term debt of $55.80M and cash and equivalents of $4.42B.